Literature DB >> 26232596

Inflammatory group 2 innate lymphoid cells.

Yuefeng Huang1, William E Paul2.   

Abstract

Group 2 innate lymphoid cells (ILC2 cells) are able to produce type 2 cytokines and to mediate type 2 immune protection and tissue homeostasis. ILC2 cells have often been considered to be a single set of cells that respond to IL-33 and/or IL-25. Recent evidence now indicates that ILC2 cells can be grouped into two distinct subsets: homeostatic or natural ILC2s (nILC2 cells); and inflammatory ILC2 cells (iILC2 cells). nILC2 cells reside in barrier tissues and primarily respond to IL-33. They play critical roles not only in immune protection but also in tissue repair and beige fat biogenesis. iILC2 cells are not present in peripheral tissues in the steady state but can be elicited at many sites by helminth infection or IL-25 treatment. IL-25-elicited ilLC2 cells act as transient ILC progenitors with multipotency. They can be mobilized by distinct types of infections to develop into nILC2-like or ILC3-like cells, functioning in corresponding immune responses. The demonstration of the existence of iILC2 cells adds to our understanding of the complexity of ILC2 biology and makes necessary an analysis of the relationship between nILC2 cells and iILC2 cells. Published by Oxford University Press on behalf of The Japanese Society for Immunology 2015.

Entities:  

Keywords:  IL-25; IL-33; ILC plasticity; iILC2; nILC2

Mesh:

Substances:

Year:  2015        PMID: 26232596      PMCID: PMC4715228          DOI: 10.1093/intimm/dxv044

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  64 in total

1.  Critical role of p38 and GATA3 in natural helper cell function.

Authors:  Jun-ichi Furusawa; Kazuyo Moro; Yasutaka Motomura; Kazuo Okamoto; Jinfang Zhu; Hiroshi Takayanagi; Masato Kubo; Shigeo Koyasu
Journal:  J Immunol       Date:  2013-07-12       Impact factor: 5.422

2.  Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice.

Authors:  L Y Drake; K Iijima; H Kita
Journal:  Allergy       Date:  2014-06-17       Impact factor: 13.146

3.  New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25.

Authors:  Stephen D Hurst; Tony Muchamuel; Daniel M Gorman; Jonathan M Gilbert; Theresa Clifford; Sylvia Kwan; Satish Menon; Brian Seymour; Craig Jackson; Ted T Kung; Joan K Brieland; Sandra M Zurawski; Richard W Chapman; Gerard Zurawski; Robert L Coffman
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

4.  Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells.

Authors:  Roel G J Klein Wolterink; Nicolas Serafini; Menno van Nimwegen; Christian A J Vosshenrich; Marjolein J W de Bruijn; Diogo Fonseca Pereira; Henrique Veiga Fernandes; Rudi W Hendriks; James P Di Santo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-03       Impact factor: 11.205

5.  Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity.

Authors:  Hong-Erh Liang; R Lee Reinhardt; Jennifer K Bando; Brandon M Sullivan; I-Cheng Ho; Richard M Locksley
Journal:  Nat Immunol       Date:  2011-12-04       Impact factor: 25.606

6.  Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system.

Authors:  David Voehringer; Tiffany A Reese; Xiaozhu Huang; Kanade Shinkai; Richard M Locksley
Journal:  J Exp Med       Date:  2006-05-15       Impact factor: 14.307

7.  A committed precursor to innate lymphoid cells.

Authors:  Michael G Constantinides; Benjamin D McDonald; Philip A Verhoef; Albert Bendelac
Journal:  Nature       Date:  2014-02-09       Impact factor: 49.962

Review 8.  Host protective roles of type 2 immunity: parasite killing and tissue repair, flip sides of the same coin.

Authors:  Judith E Allen; Tara E Sutherland
Journal:  Semin Immunol       Date:  2014-07-11       Impact factor: 11.130

9.  Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice.

Authors:  Emily Hams; Richard M Locksley; Andrew N J McKenzie; Padraic G Fallon
Journal:  J Immunol       Date:  2013-10-28       Impact factor: 5.422

10.  Direct control of hepatic glucose production by interleukin-13 in mice.

Authors:  Kristopher J Stanya; David Jacobi; Sihao Liu; Prerna Bhargava; Lingling Dai; Matthew R Gangl; Karen Inouye; Jillian L Barlow; Yewei Ji; Joseph P Mizgerd; Ling Qi; Hang Shi; Andrew N J McKenzie; Chih-Hao Lee
Journal:  J Clin Invest       Date:  2012-12-21       Impact factor: 14.808

View more
  39 in total

1.  Inhibitors of class I histone deacetylases attenuate thioacetamide-induced liver fibrosis in mice by suppressing hepatic type 2 inflammation.

Authors:  Zhixuan Loh; Rebecca L Fitzsimmons; Robert C Reid; Divya Ramnath; Andrew Clouston; Praveer K Gupta; Katharine M Irvine; Elizabeth E Powell; Kate Schroder; Jennifer L Stow; Matthew J Sweet; David P Fairlie; Abishek Iyer
Journal:  Br J Pharmacol       Date:  2019-08-17       Impact factor: 8.739

Review 2.  Innate lymphoid cells in autoimmunity: emerging regulators in rheumatic diseases.

Authors:  Medya M Shikhagaie; Kristine Germar; Suzanne M Bal; Xavier Romero Ros; Hergen Spits
Journal:  Nat Rev Rheumatol       Date:  2017-02-02       Impact factor: 20.543

3.  IL-17-producing ST2+ group 2 innate lymphoid cells play a pathogenic role in lung inflammation.

Authors:  Ting Cai; Jinxin Qiu; Yan Ji; Wenjing Li; Zhaoyun Ding; Caixia Suo; Jiali Chang; Jingjing Wang; Rui He; Youcun Qian; Xiaohuan Guo; Liang Zhou; Huiming Sheng; Lei Shen; Ju Qiu
Journal:  J Allergy Clin Immunol       Date:  2018-04-03       Impact factor: 10.793

4.  S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense.

Authors:  Yuefeng Huang; Kairui Mao; Xi Chen; Ming-An Sun; Takeshi Kawabe; Weizhe Li; Nicholas Usher; Jinfang Zhu; Joseph F Urban; William E Paul; Ronald N Germain
Journal:  Science       Date:  2018-01-05       Impact factor: 47.728

Review 5.  Mast cells as sources of cytokines, chemokines, and growth factors.

Authors:  Kaori Mukai; Mindy Tsai; Hirohisa Saito; Stephen J Galli
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

6.  Type 2 innate lymphoid cells participate in IL-33-stimulated Th2-associated immune response in chronic obstructive pulmonary disease.

Authors:  Min Jiang; Simin Tao; Shaohua Zhang; Jing Wang; Fengbo Zhang; Fengsen Li; Jianbing Ding
Journal:  Exp Ther Med       Date:  2019-08-20       Impact factor: 2.447

Review 7.  Interleukin-33 in health and disease.

Authors:  Foo Yew Liew; Jean-Philippe Girard; Heth Roderick Turnquist
Journal:  Nat Rev Immunol       Date:  2016-09-19       Impact factor: 53.106

8.  Male-specific IL-33 expression regulates sex-dimorphic EAE susceptibility.

Authors:  Abigail E Russi; Mark E Ebel; Yuchen Yang; Melissa A Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-29       Impact factor: 11.205

9.  Type 2 Innate Lymphoid Cells Impede IL-33-Mediated Tumor Suppression.

Authors:  Alan Long; Donye Dominguez; Lei Qin; Siqi Chen; Jie Fan; Minghui Zhang; Deyu Fang; Yi Zhang; Timothy M Kuzel; Bin Zhang
Journal:  J Immunol       Date:  2018-10-29       Impact factor: 5.422

Review 10.  Pulmonary group 2 innate lymphoid cells: surprises and challenges.

Authors:  Malcolm R Starkey; Andrew Nj McKenzie; Gabrielle T Belz; Philip M Hansbro
Journal:  Mucosal Immunol       Date:  2019-01-21       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.